Literature DB >> 10453940

Growth hormone/insulin-like growth factor 1 axis alterations contribute to disturbed protein metabolism in cirrhosis patients after hepatectomy.

T Inaba1, H Saito, T Inoue, I Han, S Furukawa, T Matsuda, S Ikeda, T Muto.   

Abstract

BACKGROUND/AIM: Liver cirrhosis is accompanied by a fall in whole-body protein turnover and alterations of the growth hormone (GH)/insulin-like growth factor 1 (IGF-1) axis. However, the influence of liver cirrhosis on the GH/IGF-1 axis in the perioperative period, and the contribution of the GH/IGF-1 axis alteration in cirrhosis to postoperative nitrogen metabolism are not known.
METHODS: Plasma GH, IGF-1 and IGF binding protein 3 (IGF-BP3) levels were measured sequentially in patients undergoing hepatectomy with or without cirrhosis. Postoperative nitrogen excretion and whole-body protein turnover rate were also determined.
RESULTS: Preoperative plasma IGF-1 level showed a negative correlation with indocyanine green retention rate. Cirrhosis patients undergoing hepatectomy had low IGF-1 and IGF-BP3 levels, despite extremely high GH levels in the perioperative period. Perioperative IGF-1 levels were lower in patients with postoperative complications than in those without complications. Postoperative nitrogen excretion was higher and whole-body protein turnover rate was lower in patients with cirrhosis than in those without cirrhosis. The post-operative IGF-1 level showed a positive correlation with whole-body protein turnover rate.
CONCLUSIONS: Postoperative hepatic IGF-1 production may be severely disturbed in patients with cirrhosis, and the impaired IGF-1 production contributes to the suppressed postoperative protein metabolism in cirrhosis. It may be appropriate to increase plasma IGF-1 level in patients with cirrhosis to enhance postoperative protein metabolism and improve the postoperative outcome.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10453940     DOI: 10.1016/s0168-8278(99)80224-4

Source DB:  PubMed          Journal:  J Hepatol        ISSN: 0168-8278            Impact factor:   25.083


  6 in total

1.  Disturbed synthesis of insulinlike growth factor I and its binding proteins may influence renal function changes in liver cirrhosis.

Authors:  C M Fernández-Rodriguez; I Prada; A Andrade; M Moreiras; R Guitián; R Aller; J L Lledó; G Cacho; J Quiroga; J Prieto
Journal:  Dig Dis Sci       Date:  2001-06       Impact factor: 3.199

2.  Impact of Helicobacter pylori infection on ghrelin and various neuroendocrine hormones in plasma.

Authors:  Hajime Isomoto; Hiroaki Ueno; Yoshito Nishi; Chun-Yang Wen; Masamitsu Nakazato; Shigeru Kohno
Journal:  World J Gastroenterol       Date:  2005-03-21       Impact factor: 5.742

3.  Effects of parenteral nutrition with and without GH on the GH/IGF-1 axis after hepatectomy in hepatocellular carcinoma with liver cirrhosis.

Authors:  Jie Cao; Shimin Luo; Lijian Liang; Jiaming Lai; Shanming Chen
Journal:  Front Med China       Date:  2007-07-01

4.  Clinical significance of serum IGF-I, IGF-II and IGFBP-3 in liver cirrhosis.

Authors:  Yun-Lin Wu; Jing Ye; Shu Zhang; Jie Zhong; Rong-Ping Xi
Journal:  World J Gastroenterol       Date:  2004-09-15       Impact factor: 5.742

5.  Serum concentrations of insulin-like growth factor-I (igf-I) as a marker of liver fibrosis in patients with chronic hepatitis C.

Authors:  Vicente Lorenzo-Zúñiga; Ramon Bartolí; Helena Masnou; Silvia Montoliu; Rosa Ma Morillas; Ramon Planas
Journal:  Dig Dis Sci       Date:  2007-04-05       Impact factor: 3.199

Review 6.  Human conditions of insulin-like growth factor-I (IGF-I) deficiency.

Authors:  Juan E Puche; Inma Castilla-Cortázar
Journal:  J Transl Med       Date:  2012-11-14       Impact factor: 5.531

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.